Joana R A Loureiro, Ashish K Sahib, Megha Vasavada, Amber Leaver, Antoni Kubicki, Benjamin Wade, Shantanu Joshi, Gerhard Hellemann, Eliza Congdon, Roger P Woods, Randall Espinoza, Katherine L Narr
Patients with major depressive disorder (MDD) exhibit impaired control of cognitive and emotional systems, including deficient response selection and inhibition. Though these deficits are typically attributed to abnormal communication between macro-scale cortical networks, altered communication with the cerebellum also plays an important role. Yet, how the circuitry between the cerebellum and large-scale functional networks impact treatment outcome in MDD is not understood. We thus examined how ketamine, which elicits rapid therapeutic effects in MDD, modulates cerebro-cerebellar circuitry during response-inhibition using a functional imaging NoGo/Go task in MDD patients (N = 46, mean age: 39...
September 9, 2021: NeuroImage: Clinical